Drreddys Laboratories | RDY - Current Assets


Drreddys Laboratories reported INR301.98B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
ANI Pharmaceuticals USD 747.08M 6.03M Mar/2026
Aurora Cannabis CAD 397.45M 48.38M Mar/2026
Bayer EUR 35.3B 2.39B Mar/2026
Canopy Growth CAD 529.47M 4.8M Mar/2026
Cipla INR 241.47B 7.71B Mar/2026
Corcept Therapeutics USD 439.68M 13.64M Jun/2026
Drreddys Laboratories INR 301.98B 298.66B Mar/2026
GlaxoSmithKline GBP 17.56B 202M Jun/2026
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Lonza CHF 8B 3.41B Dec/2025
Novartis USD 27.35B 744M Jun/2026
Pacira USD 615.21M 100.25M Jun/2026
Phibro Animal Health USD 894.07M 31.88M Mar/2026
Prestige Brands USD 431.48M 1.94M Mar/2026
Richter Gedeon HUF 841.24B 69.09B Mar/2026
Sun Pharmaceuticals INR 638.6B 37.24B Mar/2026
Supernus Pharmaceuticals USD 723.5M 8.08M Jun/2026
Teva Pharmaceutical Industries USD 13.76B 50M Jun/2026